Literature DB >> 20461637

Stem cell tourism and the power of hope.

Charles E Murdoch1, Christopher Thomas Scott.   

Abstract

This paper explores the notions of hope and how individual patient autonomy can trump carefully reasoned ethical concerns and policies intended to regulate stem cell transplants. We argue that the same limits of knowledge that inform arguments to restrain and regulate unproven treatments might also undermine our ability to comprehensively dismiss or condemn them. Incautiously or indiscriminately reasoned policies and attitudes may drive critical information and data underground, impel patients away from working with clinical researchers, and tread needlessly on hope, the essential motivator of patients, advocates and researchers alike. We offer recommendations to clinicians and health care providers to help balance the discourse with individuals seeking treatment while guarding against fraud, misconception, and patient harm.

Entities:  

Mesh:

Year:  2010        PMID: 20461637     DOI: 10.1080/15265161003728860

Source DB:  PubMed          Journal:  Am J Bioeth        ISSN: 1526-5161            Impact factor:   11.229


  21 in total

1.  Stem cell tourism and Canadian family physicians.

Authors:  Timothy Caulfield; Amy Zarzeczny
Journal:  Can Fam Physician       Date:  2012-04       Impact factor: 3.275

2.  Perspectives on strategies and challenges in the conversation about stem cells for spinal cord injury.

Authors:  K J Jacob; B K Kwon; C Lo; J Snyder; J Illes
Journal:  Spinal Cord       Date:  2015-06-02       Impact factor: 2.772

3.  Ethics and policy issues for stem cell research and pulmonary medicine.

Authors:  Justin Lowenthal; Jeremy Sugarman
Journal:  Chest       Date:  2015-03       Impact factor: 9.410

Review 4.  Regulation of Stem Cell Technology in Malaysia: Current Status and Recommendations.

Authors:  Nishakanthi Gopalan; Siti Nurani Mohd Nor; Mohd Salim Mohamed
Journal:  Sci Eng Ethics       Date:  2019-05-23       Impact factor: 3.525

5.  Chinese newspaper coverage of (unproven) stem cell therapies and their providers.

Authors:  Ubaka Ogbogu; Li Du; Christen Rachul; Lisa Bélanger; Timothy Caulfield
Journal:  Stem Cell Rev Rep       Date:  2013-04       Impact factor: 5.739

Review 6.  Concise Review: A Comprehensive Analysis of Reported Adverse Events in Patients Receiving Unproven Stem Cell-Based Interventions.

Authors:  Gerhard Bauer; Magdi Elsallab; Mohamed Abou-El-Enein
Journal:  Stem Cells Transl Med       Date:  2018-07-31       Impact factor: 6.940

7.  Fraudsters operate and officialdom turns a blind eye: a proposal for controlling stem cell therapy in China.

Authors:  Li Jiang; Bing He Dong
Journal:  Med Health Care Philos       Date:  2016-09

8.  Unproven Stem Cell-Based Interventions: Advancing Policy through Stakeholder Collaboration.

Authors:  Kirstin R W Matthews; Ana S Iltis
Journal:  Tex Heart Inst J       Date:  2017-06-01

Review 9.  Great expectations: autism spectrum disorder and induced pluripotent stem cell technologies.

Authors:  Emily Yang Liu; Christopher Thomas Scott
Journal:  Stem Cell Rev Rep       Date:  2014-04       Impact factor: 5.739

10.  In delicate balance: stem cells and spinal cord injury advocacy.

Authors:  Sara Parke; Judy Illes
Journal:  Stem Cell Rev Rep       Date:  2011-09       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.